Table 1.
Hematological and biochemical date of study groups.
|
β-TT (n: 154) |
IDA (n: 136) | |||
|---|---|---|---|---|
| Range | Mean ± SD | Range | Mean ± SD | |
| Hb (g/dL) total | 9–11.46 | 10.39 ± 0.69 | 8.7–11.42 | 10.23 ± 0.95 |
| RBC (×106/L) | 4.34–6.54 | 5.56 ± 0.4 | 3.45–6.33 | 4.84 ± 0.59 |
| MCV (fL) | 52.1–71 | 60.11 ± 3.49 | 45.3–79.53 | 67.49 ± 7.14 |
| MCH (pg) | 16.3–23.8 | 18.9 ± 1.37 | 13.65–27.7 | 21.33 ± 3.09 |
| RDW (%) | 13.9–24.63 | 16.76 ± 1.83 | 12.5–28.66 | 17.4 ± 3.48 |
| SI (µg/dL) | 20–194 | 76.6 ± 29.2 | 4.6–31.2 | 23.74 ± 9.48 |
| SIBC (µg/dL) | 257–472 | 339 ± 40.47 | 279–495 | 392 ± 41.74 |
| TS (%) | 5.5–55.2 | 22.88 ± 8.7 | 0.9–8.7 | 6.1 ± 2.6 |
| Ferritin (ng/mL) | 11.2–96 | 33.75 ± 22.9 | 1.1–11.2 | 7.54 ± 3.2 |
β-TT: beta thalassemia trait; IDA: iron deficiency anemia; Hb: hemoglobin; RBC: red blood cell; MCV: mean corpuscular volume; MCH: mean corpuscular hemoglobin; RDW: red blood cell distribution width; SI: serum iron; SIBC: serum iron binding capacity; TS: transferrin saturation.